Skip to main content
Clinical Trials/IRCT20091027002639N23
IRCT20091027002639N23
Completed
Phase 2

Evaluation of efficacy of topiramate alone and topiramate with omega-3 fatty acid in prophylaxis of headaches in 5-15 year old children with migraine

Yazd University of Medical Sciences0 sites60 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
migraine headache.
Sponsor
Yazd University of Medical Sciences
Enrollment
60
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Yazd University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • children aged 5\-15 years old
  • having migraine headache based on International Headache Society Criteria
  • having one or more headache attack per week
  • having moderate or severe headache disability
  • have not received omega\-3 combinations within the past two months
  • did not use any migraine preventive therapy

Exclusion Criteria

  • secondary headaches such as epilepsy or other neurologic disorders
  • allergy to topiramat or omega\-3
  • discontinuation of drugs usage for more than one week
  • irregullar drugs usage

Outcomes

Primary Outcomes

Not specified

Similar Trials